SOLARINDSBSESolar Industries India Ltd· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 15 May, 2026 · 14:45 IST

Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2026.

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults RestatedResults View source PDFExplain this filing

SOLARINDS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.0%Reaction day
₹16670.00
prior close
₹17268.00
announcement price
In-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.3%+4.4% vs market
Chemicals & Petrochemicals peers, median of 191sector · industry level-0.7%+4.7% vs sector

On the reaction day the stock moved 4.4 pts more than Nifty 100 and 4.7 pts more than its Chemicals & Petrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.0
15m
+0.1
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.0-0.3+4.4-0.7+4.7
Next day
+8.0-0.5+8.5-2.1+10.2
2d
+8.6-0.5+9.1-1.6+10.2
3d
+9.8-0.3+10.0-1.4+11.2
4d
+10.4-0.2+10.6-1.1+11.4
5d
+8.5+0.1+8.5-1.3+9.8
1w
+11.0+1.0+9.9-0.3+11.2
15d
+8.3-2.2+10.5-2.6+10.8
1m
+4.0+1.0+3.0-1.0+5.0
2m
+9.8+1.9+7.9-1.6+11.4
3m
+20.0+3.3+16.7+2.4+17.6
UpDownMarket · Nifty 100Sector · Chemicals & Petrochemicals peers, median of 191Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Solar Industries India reported strong FY26 results with consolidated revenue of Rs 9,838 crore, up 30.5% from Rs 7,540 crore in FY25. Net profit grew 34.8% to Rs 1,737 crore from Rs 1,288 crore. Standalone revenue rose 25.2% to Rs 5,579 crore with net profit up 52% to Rs 1,222 crore. The company applied Ind AS 29 (hyperinflation accounting) for its Turkish subsidiaries with a net restatement impact of Rs 94.53 crore debited to expenses. Results were also restated due to final fair value determination of Problast Group acquisition (completed July 2024), with goodwill finalized at Rs 117.27 crore. The board recommended a 550% dividend (Rs 11 per share). Operating margins expanded to 24.1% consolidated and 26.2% standalone. Debt-to-equity ratio remains healthy at 0.23.

Likely market impact

Strong growth trajectory with 30%+ revenue and PAT expansion. The restatement of prior period figures and hyperinflation impact on Turkish operations are notable but do not indicate any fundamental concerns. Healthy financial metrics support continued positive sentiment.